HRT Financial’s Westlake Chemical Partners WLKP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$987K Buy
44,681
+26,293
+143% +$564K ﹤0.01% 2064
2025
Q4
$349K Sell
18,388
-14,022
-43% -$271K ﹤0.01% 2303
2025
Q3
$680K Sell
32,410
-6,535
-17% -$143K ﹤0.01% 1714
2025
Q2
$860K Buy
38,945
+19,382
+99% +$439K ﹤0.01% 1342
2025
Q1
$451K Buy
19,563
+1,824
+10% +$43.4K ﹤0.01% 1522
2024
Q4
$410K Sell
17,739
-7,567
-30% -$174K ﹤0.01% 1549
2024
Q3
$567K Buy
25,306
+6,326
+33% +$144K ﹤0.01% 1533
2024
Q2
$428K Buy
18,980
+5,294
+39% +$118K ﹤0.01% 1360
2024
Q1
$303K Sell
13,686
-356
-3% -$7.99K ﹤0.01% 1543
2023
Q4
$304K Buy
+14,042
New +$306K ﹤0.01% 1619
2019
Q4
Sell
-9,819
Closed -$228K 1705
2019
Q3
$228K Buy
+9,819
New +$222K 0.01% 1083

Other funds holding WLKP

HRT Financial's WLKP Position: Q1 2026 in Review

HRT Financial increased its Westlake Chemical Partners (WLKP) stake by 143% in Q1 2026, buying an estimated $564K and bringing the position to 44,681 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

HRT Financial first reported a position in WLKP in Q3 2019 and has held it in 11 quarters since. 57 funds tracked by Wall St. Rank hold WLKP as of Q1 2026.

  • HRT Financial held 44,681 shares of Westlake Chemical Partners worth $987K as of Q1 2026.
  • HRT Financial bought 26,293 Westlake Chemical Partners shares in Q1 2026, an estimated $564K.
  • Westlake Chemical Partners made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2064 holding.
  • HRT Financial first reported a position in Westlake Chemical Partners in Q3 2019 and has held it in 11 quarters since.
  • 57 funds tracked by Wall St. Rank held Westlake Chemical Partners as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.